Trial Profile

Efficacy Study of Inecalcitol in Combination With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 06 Dec 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Inecalcitol (Primary) ; Decitabine
Indications Acute myeloid leukaemia
Focus Therapeutic Use
Sponsors ATON

Most Recent Events

02 Nov 2018 The trial has been discontinued in Belgium.
30 Jun 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2018.
12 May 2017 According to a Hybrigenics media release, the company expects data from this trial in first half of 2019 (H119).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com